Trial Profile
Effect of different tocilizumab treatment on disease activity and drug-free remission in patients with systemic-onset juvenile idiopathic arthritis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Jul 2015
Price :
$35
*
At a glance
- Drugs Tocilizumab (Primary)
- Indications Juvenile rheumatoid arthritis
- Focus Therapeutic Use
- 23 Jul 2015 New trial record